 |
| Health News > FDA Approves First Generic Aricept to Treat Dementia Related to Alzheimers Disease | 
|
ADVERTISEMENT | ADVERTISE WITH US
Health News Videos
The Importance of Monitoring Vitamin D Status in the U.S.
Dr. Howard Nash
The Importance of Monitoring Vitamin D Status in the U.S.
Dr. Howard Nash
The NIH Common Fund's Human Microbiome Project
Top News
Subscribe to this feed:
FDA Approves First Generic Aricept to Treat Dementia Related to Alzheimers Disease Generic Aricept Alzheimers Disease
« Back
Via FDA Press - The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease.
Although other generic versions of donepezil hydrochloride are already available, the orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier to take the medication for older or disabled patients who have difficulty swallowing.
Generics offer greater access to health care for all Americans,? said Gary Buehler, director of the FDA's Office of Generic Drugs. Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigorous standards as the brand-name drug and are the same as the branded in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with Alzheimer's disease, symptoms first appear after age 60. Alzheimer's disease is the most common cause of dementia among older people, but it is not a normal part of aging.
Dementia refers to a decline in cognitive function that interferes with daily life and activities.
Alzheimer's disease starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain.The generic donepezil hydrochloride orally disintegrating tablets, manufactured by Mutual Pharmaceutical of Philadelphia, have been approved in 5 milligram and 10 mg strengths.
For more information:Consumer Education: Generic Drugshttp://www.fda.gov/Drugs/ResourcesForYou/ucm167906.htm#
Source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm194173.htm
FDA Approves First Generic Aricept to Treat Dementia Related to Alzheimers Disease
| Dec 15th 2009 | Drugs Alzheimer's Disease FEATURED |
Via FDA Press - The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease.
Although other generic versions of donepezil hydrochloride are already available, the orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier to take the medication for older or disabled patients who have difficulty swallowing.
Generics offer greater access to health care for all Americans,? said Gary Buehler, director of the FDA's Office of Generic Drugs. Health care professionals and consumers can be assured that FDA-approved generic drugs have met the same rigorous standards as the brand-name drug and are the same as the branded in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with Alzheimer's disease, symptoms first appear after age 60. Alzheimer's disease is the most common cause of dementia among older people, but it is not a normal part of aging.
Dementia refers to a decline in cognitive function that interferes with daily life and activities.
Alzheimer's disease starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain.The generic donepezil hydrochloride orally disintegrating tablets, manufactured by Mutual Pharmaceutical of Philadelphia, have been approved in 5 milligram and 10 mg strengths.
For more information:Consumer Education: Generic Drugshttp://www.fda.gov/Drugs/ResourcesForYou/ucm167906.htm#
Source: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm194173.htm
Related articles
- Mental Decline Thwarted in Aging Rats
- Gene Linked to Alzheimers Disease Plays Key Role in Cell Survival
- Scientists Identify Two Gene Variants Associated with Alzheimers Risk
- Increased Risk of Stroke Linked to Genetic Variants
- Scientists Report Important Step in Biomarker Testing for Alzheimer
- Researchers Develop DNA Patch For Canine Form of Muscular Dystrophy
Add your own comments
Comments:
No commentsHealth Resource Centers
|
Copyright 2009-2010 Emma Concepts, Inc. All rights reserved. |
About us & FAQ |
Terms of Service |
Privacy Policy |
Advertise
Healthimize.coms content is for educational purposes only and this page and other pages on Healthimize do not contain medical advice. The information on this website is not a substitute for professional medical advice. Users further agree to abide by the terms of service. Trademarks are properties of their respective owners. |